Loading…

Clinical implication of an impaired fasting glucose and prehypertension related to new onset atrial fibrillation in a healthy Asian population without underlying disease: a nationwide cohort study in Korea

For healthy populations without comorbidities, whether prehypertension and impaired fasting glucose (IFG) are associated with new onset atrial fibrillation (AF) is not well known. We included 366 507 subjects (age ≥20 years) not diagnosed with non-valvular AF from the Korean National Health Insuranc...

Full description

Saved in:
Bibliographic Details
Published in:European heart journal 2017-09, Vol.38 (34), p.2599-2607
Main Authors: Lee, Sean S, Ae Kong, Kyoung, Kim, Daehoon, Lim, Yeong-Min, Yang, Pil-Sung, Yi, Jeong-Eun, Kim, Minsuk, Kwon, Kihwan, Bum Pyun, Wook, Joung, Boyoung, Park, Junbeom
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:For healthy populations without comorbidities, whether prehypertension and impaired fasting glucose (IFG) are associated with new onset atrial fibrillation (AF) is not well known. We included 366 507 subjects (age ≥20 years) not diagnosed with non-valvular AF from the Korean National Health Insurance Service-National Sample Cohort (NHIS-NSC) from 2003 to 2008. In total, 139 306 subjects diagnosed with AF-related comorbidities were excluded, and a 227 102 healthy population was followed up until 2013. The body mass index (BMI), blood pressure (BP), and fasting blood glucose (BG) level were acquired during National health check-ups. Subjects with IFG [hazard ratio (HR) 1.16, P = 0.017] had a higher AF risk and the diastolic BP (HR 1.11, P = 0.045) was a stronger indicator for an AF incidence than the systolic BP. After dividing the subjects into two mutually exclusive groups, AF incidence was increased dramatically by the combination effect of both prehypertension and an IFG in BMI
ISSN:0195-668X
1522-9645
DOI:10.1093/eurheartj/ehx316